[Federal Register Volume 87, Number 35 (Tuesday, February 22, 2022)]
[Notices]
[Pages 9622-9623]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03709]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-22-1268]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Drug Overdose Surveillance and Epidemiology 
(DOSE)'' to the Office of Management and Budget (OMB) for review and 
approval. CDC previously published a ``Proposed Data Collection 
Submitted for Public Comment and Recommendations'' notice on April 26, 
2021, to obtain comments from the public and affected agencies. CDC 
received four comments related to the previous notice. This notice 
serves to allow an additional 30 days for public and affected agency 
comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Drug Overdose Surveillance and Epidemiology (DOSE) (OMB Control No. 
0920-1268, Exp. 8/31/2022)--Revision--National Center for Injury 
Prevention and Control (NCIPC), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    In 2020, a total of 91,799 drug overdose deaths occurred, 
corresponding to an age-adjusted rate of 28.3 per 100,000 population 
and a 31% increase from the 2019 rate (21.6). From 2013 to 2019, the 
synthetic opioid-involved death rate increased 1,040%, from 1.0 to 11.4 
per 100,000 age-adjusted (3,105 to 36,359). The psychostimulant-
involved death rate increased 317%, from 1.2 (3,627) in 2013 to 5.0 
(16,167) in 2019. Non-fatal overdoses are on the rise as well; 
Emergency Department (ED) data from DOSE indicates increases from 2018 
to present. In response to the growing severity of the opioid overdose 
epidemic, the U.S. government declared the opioid overdose epidemic a 
public health emergency on October 26, 2017. The opioid overdose 
epidemic is one of the top priorities of the U.S. Department of Health 
and Human Services (HHS). In

[[Page 9623]]

2021, HHS expanded their Overdose Prevention Strategy to focus on four 
strategic priorities: Primary prevention, harm reduction, evidence-
based treatment, and recovery support.
    DOSE is a critical element of HHS's first goal under primary 
prevention to support research and surveillance to collect timelier and 
more specific data through accelerating the speed at which CDC reports 
drug overdose data. DOSE data collection integrates, expands, and 
enhances previous data sharing efforts with public health departments 
initiated under ESOOS. The goal of DOSE is to conduct surveillance of 
approximately 75% of all ED visits for drug overdoses through the end 
of the Overdose Data to Action (OD2A) cooperative agreement in 2023. In 
2019, OD2A provided funding for 66 jurisdictions; 47 states and the 
District of Columbia share data with DOSE. Though we had hoped to 
capture data from all 50 states and the District of Columbia, only 47 
states and the District of Columbia applied for this funding 
announcement.
    Currently, DOSE operates in the 47 states and the District of 
Columbia currently funded by OD2A (three states did not request CDC 
funding in the current cycle but may for the next funding cycle in 
2023). Of these 48 health departments, 43 share syndromic data with CDC 
monthly and 26 share at least quarterly discharge data. A total of 33 
health departments provide CDC with access to their syndromic 
surveillance data from EDs in CDC's National Syndromic Surveillance 
Program (NSSP) system. Access to this timely data has allowed us to 
improve the situational awareness of federal, state, and local health 
departments about emerging drug overdose outbreaks and the progression 
of the opioid overdose epidemic. Health departments have used this data 
to populate state data dashboards and develop alerts for local 
communities. In addition, health departments have used this data in 
concert with public safety partners to gain a better overall picture of 
outbreaks in their communities.
    All data sharing between CDC and health departments in DOSE is 
driven by two standardized data forms, the Rapid ED overdose data form 
and the ED discharge overdose data form, and CDC cases definitions of 
drug, opioid, heroin, fentanyl, all stimulant, cocaine, 
methamphetamine, benzodiazepine, and other emerging drug overdoses. The 
Rapid ED Overdose Data Form will be submitted to CDC monthly. For 35 
respondents, the estimated burden per response is 30 minutes. For 10 
respondents, the estimated burden per response is three hours. The 
estimated burden per response for the ED Discharge Overdose Data Form 
is three hours. This form will be submitted four times per year by 28 
respondents and once per year by 23 respondents. All information will 
be collected electronically. The total estimated annualized burden 
hours are 975.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondent                    Form name            Number of     responses per   per response
                                                                    respondents     respondent        (hours)
----------------------------------------------------------------------------------------------------------------
Participating health departments        Rapid ED overdose data                10              12               3
 sharing aggregate data from local       form.
 syndromic or hospital discharge file.
Participating health departments        Rapid ED overdose data                35              12           30/60
 sharing case-level ED data with CDC     form.
 through the NSSP BioSense (OMB No.
 0920-0824).
Participating health department         ED discharge overdose                 28               4               3
 sharing finalized hospital discharge    data form.
 data on a quarterly basis.
Participating health department         ED discharge overdose                 23               1               3
 sharing finalized hospital discharge    data form.
 data on a yearly basis.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-03709 Filed 2-18-22; 8:45 am]
BILLING CODE 4163-19-P